Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis.
Cunniffe N, Vuong KA, Ainslie D, Baker D, Beveridge J, Bickley S, Camilleri P, Craner M, Fitzgerald D, de la Fuente AG, Giovannoni G, Gray E, Hazlehurst L, Kapoor R, Kaur R, Kozlowski D, Lumicisi B, Mahad D, Neumann B, Palmer A, Peruzzotti-Jametti L, Pluchino S, Robertson J, Rothaul A, Shellard L, Smith KJ, Wilkins A, Williams A, Coles A.
Cunniffe N, et al. Among authors: gray e.
J Neurol Neurosurg Psychiatry. 2021 Mar;92(3):295-302. doi: 10.1136/jnnp-2020-324286. Epub 2020 Nov 12.
J Neurol Neurosurg Psychiatry. 2021.
PMID: 33184094